Polyclonal antithymocyte globulins reduce the expression of IL-4 in a non-human primate model of ischemia-reperfusion injury

Transplant Immunology

Volumn 13, Issue 1, 2004, Pages 9-13

  Beiras Fernandez, Andres ^a   Thein, Eckart ^a   Chappell, Daniel ^a   Schropp, Alke ^a   Hammer, Claus ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antithymocyte globulins; Cytokines; Interleukin 4; Ischemia reperfusion injury

Indexed keywords

INTERLEUKIN 4; THYMOCYTE ANTIBODY;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LYMPHOCYTE ACTIVATION; MONKEY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; TISSUE INJURY;

ANIMALS; ANTIGENS, CD45; ANTILYMPHOCYTE SERUM; EXTREMITIES; INTERLEUKIN-4; MACACA FASCICULARIS; MUSCLE, SKELETAL; PRIMATES; REPERFUSION INJURY; T-LYMPHOCYTES;

EID: 2942627807     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.01.002     Document Type: Article

References (40)

1. Witko-Sarsat V., Rieu P., Descamps-Latscha B., Lesavre P., Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest. 80:2000;617-653
2. Cavanagh S.P., Gough M.J., Homer-Vanniasinkam S. The role of the neutrophil in ischaemia-reperfusion injury: potential therapeutic interventions. Cardiovasc Surg. 6:(2):1998;112-118
3. Frangogiannis N.G., Youker K.A., Rossen R.D., et al. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 30:(12):1998;2567-2576
4. Li C., Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Cell Physiol. 282:(2):2002;C227-241
5. Redmond H.P., Grace P., Daly J.M., Bouchier-Hayes D.J. Essential surgical immunology. 1st ed:1996;Churchill-Livingstone, Edinburgh
6. Seekamp A., Till G.O., Mulligan M.S., et al. Role for selectins in local and remote tissue injury following ischemia and reperfusion. Am J Pathol. 144:1994;592-598
7. Seekamp A., Warren J.S., Remick D.J., Till G.O., Ward P.A. Requirements for TNF-alpha and IL-1 in limb ischemia-reperfusion injury and associated lung injury. Am J Pathol. 143:1993;453-463
8. Cavaillon J.M. Pro- vs. anti-inflammatory cytokines: myth or reality. Cell Mol Biol. 47:(4):2001;695-702
9. Oleksowicz L., Dutcher J.P. A review of the new cytokines: IL-4, IL-6, IL-11, and IL-12. Am J Ther. 1:(2):1994;107-115
10. Proudfoot A.E., Power C.A., Wells T.N. The strategy of blocking the chemokine system to combat disease. Immunol Rev. 177:2000;246-256
11. Lee J.D., Swisher S.G., Mineheart E.H., McBride W.H., Economou J.S. Interleukin-4, a potent inhibitor of Interleukin-6, TNF, INF-γ and IL-1 production. Surg Forum. 41:1991;441-444
12. Brubaker J.O., Montaner L.J. Role of interleukin-13 in innate and adaptive immunity. Cell Mol Biol. 47:(4):2001;637-651
13. Fort M., Lesley R., Davidson N., Menon S., Brombacher F., Leach M., et al. IL-4 exacerbates disease in a Th1 cell transfer model of colitis. J Immunol. 166:(4):2001;2793-2800
14. Steinke J.W., Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2:(2):2001;66-67
15. Goldman M., Le Moine A., Braun M., Flamand V., Abramowicz D. A role for eosinophils in transplant rejection. Trends Immunol. 22:(5):2001;247-251
16. Moser R., Fehr J., Bruijnzeel P.L. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol. 149:1992;1432-1438
17. Bonnefoy-Berard N., Vincent C., Revillard J.P. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation. 51:(3):1991;669-673
18. Thein E., Sevilmis G., Muenzing S., Hammer C., Messmer K. Evaluation of a system for the perfusion of isolated, rodent organs. Xenotransplantation. 8:(2):May 2001;94-99
19. Hauet T., Goujon J.M., Vandewalle A., Baumert H., Lacoste L., Tillement J.P., et al. Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol. 11:(1):2000;138-148
20. Bienvenu K., Russell J., Granger D.N. Platelet-activating factor promotes shear rate-dependent leukocytes adhesion in post-capillary venules. J Lipid Mediator. 8:1993;831-836
21. Seekamp A., Mulligan M.S., Till G.O., Ward P.A. Requirements for neutraphil products and L-arginine in ischemia-reperfusion injury. Am J Pathol. 142:(4):1993;1217-1226
22. Boothby M., Mora A.L., Aronica M.A., Youn J., Sheller J.R., Goenka S., et al. IL-4 signaling, gene transcription regulation and the control of effector T cells. Immunol Res. 23:(2-3):2001;179-191
23. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signalling mechanisms and biologic functions. Annu Rev Immunol. 17:1999;701-738
24. van Roon J.A., Lafeber F.P., Bijlsma J.W. Synergistic activity of interleukin-4 and interlekin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheuma. 44:(1):2001;3-12
25. Hart P.H., Bonder C.S., Balogh J., Dickensheets H.L., Donnelly R.P., Finlay-Jones J.J. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukocyte Biol. 66:(4):1999;575-578
26. Bessis N., Boissier M.C. Novel pro-inflammatory interleukins: potential therapeutic targets in rheumatoid arthritis. Joint Bone Spine. 68:(6):2001;477-481
27. Barnes P.J. Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol. 42:2002;81-98
28. Kips J.C., Tournoy K.G., Pauwels R.A. New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5. Eur Respir J. 17:(3):2001;499-506
29. Bischoff S.C., Sellge G. Mast cell hyperplasia: role of cytokines. Int Arch Allergy Immunol. 127:(2):2002;118-122
30. Nagai S., Toi M. Interleukin-4 and breast cancer. Breast Cancer. 7:(3):2000;181-186
31. Joshi B.H., Leland P., Asher A., Prayson R.A., Varricchio F., Puri R.K. In situ expression of interleukin-4 (IL-4) receptors in human brain tumours and cytoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res. 61:(22):2001;8058-8061
32. Kaminishi K., Soma Y., Kawa Y., Mizugochi M. Flow cytrometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci. 29:(1):2002;19-25
33. Westerholm-Ormio M., Garioch J., Ketola I., Savilahti E. Inflammatory cytokines in small intestinal mucosa of patients with potential celiac disease. Clin Exp Immunol. 128:(1):2002;94-101
34. Zhu J., Majumdar S., Qiu Y., et al. Interleukin-4 and Interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells. Am J Respir Crit Care Med. 164:(12):2001;2220-2228
35. Conti F., Calmus Y., Rouer E., Gaulard P., Louvel A., Houssin D., et al. Increased expression of IL-4 during liver allograft rejection. J Hepatol. 30:(5):1999;935-943
36. Le Moine A., Flamand V., Demoor F.X., et al. Critical roles for IL-4 and IL-5 and eosinophils in chronic skin allograft rejection. J Clin Invest. 103:(12):1999;1659-1667
37. Ensminger S.M., Spriewald B.M., Sorensen H.V., et al. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD-154 costimulation. J Immunol. 167:(1):2001;532-541
38. Burger D., Dayer J.M. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes. Ann NY Acad Sci. 966:2002;464-473
39. Vella A., Teague T.K., Ihle J., et al. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med. 186:(2):1997;325-330
40. Puri R.K. Cytotoxins directed at Interleukin-4 receptors as therapy for human brain tumors. Meth Mol Biol. 166:2001;155-176